CTIS.eu › Cities › Netherlands › Amersfoort
Amersfoort
Netherlands
117 total trials
46 recruiting
2024-510617-15-00
5
Non-metastatic resectable pancreatic cancer
2024-519833-51-00
6
Behaviors that challenge
2025-523117-28-00
4
Relapsed or Refractory Multiple Myeloma
2025-523586-18-00
5
Non-Small Cell Lung Cancer
2025-523735-19-00
5
Metastatic Microsatellite Stable Colorectal Cancer
2025-524229-41-00
5
Triple negative breast cancer
2025-525013-23-00
4
Stage 4 (IV) Non-Small Cell Lung Cancer (NSCLC)
2024-519870-38-00
5
2026-05-11
Atherosclerotic cardiovascular disease (ASCVD)
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
2024-517700-12-00
5
2025-12-10
Rectal cancer
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
2023-504918-29-00
5
2024-08-22
Hormone receptor positive breast cancer
2022-501709-11-00
5
2023-06-06
Isocitrate deshydrogenase1 mutation-positive (IDH1m) acute myeloid leu
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
2023-507518-28-00
5
2022-09-13
Acute myeloid leukemia
2024-513185-19-00
9
2022-07-13
Extensive stage small cell lung cancer (ES-SCLC)
2025-523123-22-00
5
2026-05-07
Chronic Kidney Disease
2025-523804-62-00
5
2026-04-28
Obesity
2024-514874-36-01
4
2026-04-17
Refractory angina due to obstructive coronary artery disease
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
2024-519494-19-00
5
2025-12-22
Nutritional and metabolic diseases
2024-518365-10-00
5
2025-10-28
Previously Untreated Advanced or Metastatic Non-Squamous Non−Small Cel
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
Showing 1–24 of 117 trials